Translocation-associated Soft Tissue Sarcoma
1 clinical trials · Condition
◉ Watch Translocation-associated Soft Tissue Sarcoma
| Record | Firm | Date |
|---|---|---|
| XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma (NCT06571734) | Northwestern University | 2024-09-19 |
Track Translocation-associated Soft Tissue Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.